Company Quick10K Filing
Magellan Gold
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-04-15
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-07-30
10-Q 2020-03-31 Filed 2020-06-23
10-K 2019-12-31 Filed 2020-05-28
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-15
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-12
S-1 2018-12-20 Public Filing
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-06-28
10-K 2017-12-31 Filed 2018-05-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-18
10-Q 2017-03-31 Filed 2017-05-19
10-K 2016-12-31 Filed 2017-04-06
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-18
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-23
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-07
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-04-05
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
8-K 2020-11-24
8-K 2020-11-10
8-K 2020-09-17
8-K 2020-09-03
8-K 2020-09-01
8-K 2020-08-25
8-K 2020-08-18
8-K 2020-08-11
8-K 2020-08-04
8-K 2020-07-17
8-K 2020-07-15
8-K 2020-07-01
8-K 2020-07-01
8-K 2020-07-01
8-K 2020-06-16
8-K 2020-06-02
8-K 2020-05-12
8-K 2020-03-31
8-K 2020-03-27
8-K 2020-01-13
8-K 2019-12-30
8-K 2019-10-16
8-K 2019-09-30
8-K 2019-09-23
8-K 2019-07-16
8-K 2019-06-21
8-K 2019-06-01
8-K 2019-05-28
8-K 2019-02-22
8-K 2019-01-04
8-K 2018-12-17
8-K 2018-10-25
8-K 2018-10-19
8-K 2018-10-02
8-K 2018-09-25
8-K 2018-09-17
8-K 2018-09-06
8-K 2018-08-30
8-K 2018-08-20
8-K 2018-07-24
8-K 2018-07-20
8-K 2018-06-08
8-K 2018-05-18
8-K 2018-05-08
8-K 2018-03-05
8-K 2018-01-05

Magellan Gold Financials

MAGE Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash00041012000082292401071099225028
Accounts Receivable
Inventory
PP&E1,1561,2161,0831,1371,0541,0351,017961
Assets10299681221591581671752552533323323453843693494394744395706426191,9542,1561,8201,9591,5241,5691,6031,473
Accounts Payable74598086114817666737978203631385338515179114147270395410485541544580557
Long-Term Debt52525252523333333330272279
Liabilities1651581712393413884615066317438899581,0291,1161,1841,3081,4271,4211,4391,5682,0691,8833,2023,4393,5863,6584,0254,2944,6792,477
Stockholders' Equity-63-59-103-117-182-230-294-331-376-489-557-626-684-733-815-959-988-947-1,000-997-1,427-1,264-1,248-1,284-1,766-1,700-2,501-2,725-3,076-1,003
Income Statement ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue12323200
Cost of Revenue315121957496
Gross Profit-192-119-62-74-96
R&D
SG&A842123252723191525202226383461677491122155131194483221231243171314354
Tax000000000000
Net Income-9-46-199-48-65-47-64-37-46-94-67-70-58-54-97-66-271-51-172-122-894-226-895-343-549-451-337-515-3,748
Cash Flow ($'000)2011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1-20-42-76-74-49-32-97-38-33-30-57-41-96-63-79-107-78-116-165-130-176-112-74-69-210
Cash Investing-39-30-50-40000-800-1000-600-108-1000-85000-66-50-250
Cash Financing8250857975745011097138333735554219735752251761111,01423010621412098222